Introduction Chronic total occlusion (CTO) represents the most challenging setting for percutaneous coronary intervention (PCI) and multivessel coronary disease (MCD) is often treated in a staggered manner and in a deferred procedure. Although transfemoral is one of the common access site, the transradial access (TRA) has been used with similar procedural success [1]. The distal…
How does the Fellow’s Corner work?
The Fellow’s Corner is a space for discussion of real-life clinical cases, carried out in the centers of the SOLACI community. Its goal is to discuss and comment these cases making reference to the scientific evidence that supports each conduct. How does the Fellow’s Corner work? Each case should be presented in writing through the…
Send Your Clinical Case | Fellow’s Corner
In this section we will explain you how to send a clinical case for the Fellow’s Corner simply and briefly. How to send a case Cases will be sent via https://wetransfer.com/ (free file sharing site) to proeducar@solaci.org and to webservices@solaci.org If you have never used this service, watch this STEP BY STEP TUTORIAL to…
The Fellow’s Corner
The Fellow’s Corner is a space for interaction and discussion dedicated exclusively to continuing medical training and education for all interventional fellows in Latin America. In this section, we discuss real-world clinical cases from our daily practice, with the purpose of sharing experiences and reaching an agreement on possible treatment courses for different situations. Become…
Newsletter #276: Stay Updated in Interventional Cardiology
Read the #276 SOLACI Newsletter with all the news about Interventional Cardiology and events to add to your agenda.
Become a Member
Why join SOLACI? The Latin American Society of Interventional Cardiology (SOLACI) has been consistently promoting and developing interventional cardiology in our region for the past 26 years. This landmark organization is present in 20 countries across Latin America and the Caribbean; its educational programs, as well as the renowned yearly Congress and Sessions, reflect its prestige. In…
Myocardial Revascularization Surgery Hits a Plateau
Hopes were raised high by the ARTS study, when set to show the benefit of bilateral internal mammary arteries (BIMA) during coronary artery bypass graft surgery compared over the use of a single internal mammary artery (SIMA) at 10 year follow up, but only one sub-study was able to show an advantage over radial grafts.…
ICELAND MI: Unrecognized MI Have Similar Prognosis to Recognized MI
At 10-year follow-up, unrecognized or silent MIs have similar mortality to clinically recognized MI and, even though this does not justify routine screening, these findings call for more aggressive prevention. Unrecognized MI, detected by MRI, is associated to long term mortality risk similar to that of recognized MI; therefore, these patients have higher risk…
The 10 most read articles of September
1- High-Sensitivity Troponins Turned All Events into Infarctions; the 4th Universal Definition Clarifies Things Myocardial infarction or myocardial injury? The Fourth Universal Definition of Myocardial Infarction (an update of the 2012 version) is here to clarify that not all cases of elevated cardiac troponin values are acute myocardial infarctions. Read more 2- A Simple…
Direct Stenting vs. Conventional Angioplasty and Their Interaction with Thrombus Aspiration
The rates of direct stenting are higher among patients randomized to thrombus aspiration. The rates of clinical events and myocardial reperfusion did not differ significantly between a direct stenting strategy vs. predilation and stenting, and no interaction was observed as regards thrombus aspiration. Several preliminary studies have emerged from the hypothesis that a direct stenting…
SOLACI-SOCIME 2018 | Real world supported unprotected LM PCI with impella device
Read articles on the main presentations of the first day of SOLACI-SOCIME 2018 Congress. See the presentation by Dr. Cindy Grines, entitled “Real world supported unprotected LM PCI with impella device”. We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.